Stock UniverseDerived research view · source repositories remain read-only

NeoGenomics, Inc. (NEO)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
High
Selection Score
43.48
Global Rank
153
Market Cap
1.28B
Latest Close
10.90
RS Composite
5.56% · G#980

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
22.61%
3M
21.65%
6M
-10.07%
1Y
47.70%
3Y
-36.55%
5Y
-73.43%
10Y
21.52%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 984.24K · 30-day average: 1.89M · Max drawdown over stored range: -91.92%

Research Snapshot

Relative Strength vs SPX

RS Composite5.56%
20D RS19.54%
60D RS18.51%
120D RS-14.39%
Global RS Rank980 · 70.79% percentile
Qualified+ RS Rank367 · 70.83% percentile
Group ScopeQualified+
Primary RS Rank30 · 78.87% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank11 / 246
Primary Percentile95.93
Score Notesmarket-cap support, industry-tailwind, innovation-keyword

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-28n/a321.91M-106.30M-99.21M-0.77-7.90M42.83M-50.73M129Mn/an/an/an/an/a146.14Mn/a

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.77-14.1xn/an/a$-0.39-27.6x$-0.06-177.3x

Shares Diluted: 129M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue484.329509.728591.643660.566727.332
Revenue Growth (YoY)8.973%5.244%16.07%11.649%10.107%
Gross Profit187.06187.896244.604290.1313.893
Operating Income-118.754-153.107-96.648-71.095-69.645
Free Cash Flow-90.865-96.884-30.705-34.038-21.778
Free Cash Flow Per Share-0.757-0.78-0.245-0.269-0.17
EPS (Diluted) GAAP-0.07-1.161274-0.700929-0.621563-0.843279
EPS Growth9700%9700%9700%9700%9700%
EPS Non-GAAP
Gross Margin38.623%36.862%41.343%43.917%43.157%
Operating Margin-24.519%-30.037%-16.336%-10.763%-9.575%
Profit Margin-1.723%-28.299%-14.868%-11.918%-14.852%
Free Cash Flow Margin-18.761%-19.007%-5.19%-5.153%-2.994%
Shares Outstanding (Diluted)119.962124.217125.502126.658128.101
Shares Change (YoY)7.306%3.547%1.034%0.921%1.139%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-28n/an/a-18.24Mn/a-17.11Mn/an/a129.17M146.14Mn/aprocessed
2025 Q42026-02-17n/an/a-13.41Mn/a-9.88Mn/a-0.08128.65M159.62M341.86Mprocessed
2025 Q32025-10-28n/an/a-27.01Mn/a-27.13Mn/an/a128.41M164.12Mn/aprocessed
2025 Q22025-07-29n/an/a-47.63Mn/a-45.09Mn/an/a127.95M154.72Mn/aprocessed
2025 Q12025-04-29n/an/a-27.82Mn/a-25.92Mn/an/a127.38M346.19Mn/aprocessed
2024 Q42025-02-18n/an/a-18.40Mn/a-15.32Mn/a-0.12127.16M367.01M340.33Mprocessed
2024 Q32024-11-05n/an/a-21.20Mn/a-17.70Mn/an/a126.95M361.99Mn/aprocessed
2024 Q22024-07-30n/an/a-21.94Mn/a-18.64Mn/an/a126.41M355.08Mn/aprocessed
2024 Q12024-04-30n/an/a-30.57Mn/a-27.06Mn/an/a126.11M331.91Mn/aprocessed
2023 Q42024-02-20n/an/a-18.57Mn/a-14.33Mn/a-0.11125.93M342.49M338.82Mprocessed
2023 Q32023-11-06n/an/a-24.20Mn/a-18.52Mn/an/a125.69M306.24Mn/aprocessed
2023 Q22023-08-08n/an/a-29.89Mn/a-24.33Mn/an/a125.36M289.07Mn/aprocessed
2023 Q12023-05-09n/an/a-35.07Mn/a-30.80Mn/an/a125.03M275.61Mn/aprocessed
2022 Q42023-02-24n/an/a-26.38Mn/a-22.69Mn/a-0.18124.70M263.18M337.32Mprocessed
2022 Q32022-11-08n/an/a-39.51Mn/a-36.85Mn/an/a124.42M266.13Mn/aprocessed
2022 Q22022-08-09n/an/a-39.70Mn/a-35.30Mn/an/a124.07M283.64Mn/aprocessed
2022 Q12022-05-09n/an/a-52.03Mn/a-49.41Mn/an/a123.63M305.90Mn/aprocessed
2021 Q42022-02-25n/an/a-41.57Mn/a-41.76Mn/a-0.36115.78M316.83M335.83Mprocessed
2021 Q32021-11-04n/an/a-39.71Mn/a-20.35Mn/an/a122.56M340.56M335.46Mprocessed
2021 Q22021-08-09n/an/a-22.37Mn/a75.87Mn/an/a131.24M368.80M335.09Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.